Literature DB >> 34490471

Impact of Atopic Dermatitis on Work and Activity Impairment in Taiwan.

Tom C Chan1, Yi-Chun Lin, Yung-Tsu Cho, Chao-Hsiun Tang, Chia-Yu Chu.   

Abstract

Atopic dermatitis has a substantial impact on work and activity impairment according to studies from Western communities. Prospective studies of work productivity and activity impairment in Asian patients with atopic dermatitis are lacking. The aims of this study were to investigate the impacts of atopic dermatitis on work productivity and activity impairment among Taiwanese patients, and to stratify the analyses by disease severity. One-third of employed participants reported missing work (absenteeism) in the preceding week due to atopic dermatitis, while 88.5% of the remaining two-thirds reported impaired work effectiveness (presenteeism). In addition, 92.5% of all participants reported impaired daily activities. Overall work impairment (aggregate productivity loss from absenteeism and presenteeism) was 1.8- and 2.6-fold greater in subjects with moderate and severe atopic dermatitis, respectively, compared with those with mild atopic dermatitis. Presenteeism, but not absenteeism, contributes to the majority of total work impairment in this cohort. Daily activity impairment was 1.5-fold greater in moderate atopic dermatitis, and 2.0-fold greater in severe atopic dermatitis, compared with mild atopic dermatitis. Both work and activity impairment showed significant positive correlations with atopic dermatitis severity scores (SCORing Atopic Dermatitis; SCORAD). In conclusion, work productivity and activity impairment is significantly correlated with disease severity in this Taiwanese atopic dermatitis cohort. In order to obtain a full picture of disease burden to patients and caregivers, patients with atopic dermatitis should be monitored for disease activity as well as corresponding impacts on quality of life.

Entities:  

Keywords:  work impairment; work productivity and activity impairment; atopic dermatitis

Mesh:

Year:  2021        PMID: 34490471      PMCID: PMC9425596          DOI: 10.2340/00015555-3918

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   3.875


  15 in total

1.  The validity and reproducibility of a work productivity and activity impairment instrument.

Authors:  M C Reilly; A S Zbrozek; E M Dukes
Journal:  Pharmacoeconomics       Date:  1993-11       Impact factor: 4.981

2.  A prospective, interventional assessment of the impact of ustekinumab treatment on psoriasis-related work productivity and activity impairment.

Authors:  Kourosh Beroukhim; Melissa Danesh; Catherine Nguyen; Benjamin Farahnik; Ethan Levin; Argentina Leon; John Koo
Journal:  J Dermatolog Treat       Date:  2016-04-07       Impact factor: 3.359

3.  The burden of atopic dermatitis in US adults: results from the 2013 National Health and Wellness Survey.

Authors:  Jennifer Whiteley; Birol Emir; Robin Seitzman; Geoffrey Makinson
Journal:  Curr Med Res Opin       Date:  2016-06-21       Impact factor: 2.580

4.  Impact of disease severity on work productivity and activity impairment in Japanese patients with atopic dermatitis.

Authors:  Chizuko Yano; Hidehisa Saeki; Takaoki Ishiji; Yozo Ishiuji; Junko Sato; Yukari Tofuku; Hidemi Nakagawa
Journal:  J Dermatol       Date:  2013-07-09       Impact factor: 4.005

5.  Use of the Dermatology Life Quality Index work/study domain to estimate overall work productivity loss among patients with psoriasis: an analysis based on real-world data.

Authors:  N Li; A Teeple; E Muser; J Lucas; J Hetherington; T Fitzgerald
Journal:  Clin Exp Dermatol       Date:  2019-12-21       Impact factor: 3.470

6.  Differential effects of secukinumab vs. ustekinumab for treatment of psoriasis on quality of life, work productivity and activity impairment: a structural equation modelling analysis.

Authors:  D E Stull; C E M Griffiths; I Gilloteau; Y Zhao; A Guana; A Y Finlay; B Sherif; K Houghton; L Puig
Journal:  Br J Dermatol       Date:  2018-04-14       Impact factor: 9.302

7.  Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis.

Authors:  B Kunz; A P Oranje; L Labrèze; J F Stalder; J Ring; A Taïeb
Journal:  Dermatology       Date:  1997       Impact factor: 5.366

8.  Impact of psoriasis severity on patient-reported clinical symptoms, health-related quality of life and work productivity among US patients: real-world data from the Corrona Psoriasis Registry.

Authors:  Bruce Strober; Jeffrey D Greenberg; Chitra Karki; Marc Mason; Ning Guo; Peter Hur; Yang Zhao; Vivian Herrera; Feng Lin; Mark Lebwohl
Journal:  BMJ Open       Date:  2019-04-20       Impact factor: 2.692

9.  A multinational assessment of work-related productivity loss and indirect costs from a survey of patients with psoriasis.

Authors:  R Villacorta; A Teeple; S Lee; S Fakharzadeh; J Lucas; S McElligott
Journal:  Br J Dermatol       Date:  2020-01-29       Impact factor: 9.302

10.  Real-World Postmarketing Study of the Impact of Adalimumab Treatment on Work Productivity and Activity Impairment in Patients with Psoriatic Arthritis.

Authors:  Hidemi Nakagawa; Yoshiya Tanaka; Shigetoshi Sano; Hideto Kameda; Atsuo Taniguchi; Tomoko Kashiwagi; Takeshi Kawaberi; Junko Kimura; Akimichi Morita
Journal:  Adv Ther       Date:  2019-01-19       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.